Research output per year
Research output per year
Personal profile
Expertises
Acute myeloid leukemia, Myelodysplastic syndrome and allogeneic hematopoietic cell transplantation.
Main research areas
Clinical reasearch: PI/Co-investigator on national and international Clinical protocols for AML/high risk MDS patients and allogeneic transplanted patients.
Qualitative, Clinical research:
PHD study defended 2004: Acute myeloid leukemia patients' experience of illness and treatment. A qualitative study.
PhD Head Supervisor for Lene Ø Jepsen: Outpatient management of acute leukemia patients. The experience of patients and their relatives in a rehabilitation perspective. PhDdefense april 2016.
Epidemiological research based on The Danish Acute Leukemia Database - as part of the Danish Acute Leukemia Study Group.
National coordinator/PI: NMDSG14B Prospective MRD-study for allo HCT pts with myeloid diseases
Co investigator: Reach 2 and 3: ruxolitinib for acute and Chronic GvHd
PI: Nordic retrospective study of allo HCT pts with CMML
Current research
PI/national coordinator: NMDSG14B . a prospective Nordic MRD-study for allo´HCT pt with myeloid diseases
PI: a retrospective nordic study of allogeneic transplanted patients with CMML
Co-investigator: Reach 2 and 3: ruxolitinib for acute and chronic GvHd, respectively
Co-investigator: MORPHO a phase III study with the Flt3-inhibitor Gilteritinib as maintenance after allo-HCT
Part of Rigshospital's Fungus Stewardship group: Invasive aspergillus infection following allo HCT. A prospective stewardship study for diagnosis and treatment.
Potential conflicts of interest
None
Fingerprint
Dive into the research topics where Lone Smidstrup Friis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Evaluation and management of hepatic dysfunction, portal hypertension and portal/splanchnic vein thrombosis in patients with myelofibrosis undergoing allogeneic haematopoietic cell transplantation: A practice based survey on behalf of the Chronic Malignancies Working Party of the EBMT
Battipaglia, G., Polverelli, N., Tuffnell, J., Chiusolo, P., Robin, M., Gambella, M., Broers, A., Sala, E., Passweg, J., Furst, S., Friis, L. S., Dulery, R., de Witte, M., Srour, M., Finazzi, M. C., Wehr, C., Nagler, A., Richardson, D., Bethge, W. & Clark, A. & 5 others, , 2025, In: Current research in translational medicine. 73, 1, 103476.Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
Non-myeloablative Allogeneic Haematopoietic Stem Cell Transplantation for Myelofibrosis. A Population-Based Study from Eastern Denmark
Holmström, M. O., Minculescu, L., Nørgaard, K., Kornblit, B. T., Schjødt, I., Nygaard, M., Andersen, N. S., Sengeløv, H., Bruunsgaard, H., Petersen, S. L., Andersen, M. K. & Friis, L. S., 17 Mar 2025, (E-pub ahead of print) In: Transplantation and cellular therapy.Research output: Contribution to journal › Journal article › Research › peer-review
-
Outpatient management of patients conditioned with Fludarabine and Treosulfan prior to allogeneic hematopoietic cell transplantation
Schovsbo, J. S., Kjeldsen, L., Nørskov, K. H., Sengeløv, H., Kornblit, B. T., Schjødt, I., Petersen, S. L., Nygaard, M., Andersen, N. S., Mortensen, B. K. & Friis, L. S., Jan 2025, In: Transplantation and cellular therapy. 31, 1, p. 28.e1-28.e10Research output: Contribution to journal › Journal article › Research › peer-review
-
Plasma nucleosome levels and risk of acute graft-versus-host disease after myeloablative allogeneic hematopoietic stem cell transplantation: a single-center cohort study
Hansen, S. H., Ostrowski, S. R., Andersen, N. S., Friis, L. S., Kornblit, B., Petersen, S. L., Schjødt, I., Sengeløv, H. & Gjærde, L. K., May 2025, In: Transplantation and cellular therapy. 31, 5, p. 301.e1-301.e10Research output: Contribution to journal › Journal article › Research › peer-review
-
Donor Lymphocyte Infusion Is a Feasible Way to Improve Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Who Relapse after Allogeneic Stem Cell Transplantation
Minculescu, L., Reekie, J., Petersen, S. L., Kornblit, B. T., Schjoedt, I., Andersen, N. S., Andersen, L. P., Fischer-Nielsen, A., Haastrup, E. K., Friis, L. S. & Sengelov, H., 2024, In: Acta Haematologica. 147, 3, p. 325-332 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus)